Stock Events

Stock Events

enGene Therapeutics Warrants (ENGNW) Q2 2026 Earnings

15JunConfirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-0.73

-0.63

-0.53

-0.43

Details

Expected EPS

-0.466164

Actual EPS

-0.43

Surprise EPS

0.04

Surprise Percent

+7.76%

Description

enGene Therapeutics Warrants (ENGNW) has reported earnings of -0.43 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.